-
National Development and Reform Commission: Establish a coal production and circulation cost investigation system as soon as possible
Time of Update: 2023-03-21
Under normal circumstances, coal price should reflect the production and circulation cost level of the industry and the actual supply and demand situation, and operate within a reasonable range .
-
Junshi PD-1 chases the deer in the Middle East! East China Pharmaceutical, Henlius, BeiGene...The "Belt and Road" market has become a blue ocean of innovative drugs in China
Time of Update: 2023-02-02
On December 25, Junshi Biologics announced that it has reached a cooperation with Hikma MENA FZE (hereinafter referred to as "Hikma") for its PD-1 drug teripulimab. According to the announcement, Jun
-
The scale exceeds 600 billion, and innovative drug achievements are frequent Shanghai's pharmaceutical industry has shown strong resilience and vitality
Time of Update: 2022-12-04
It is reported that since the beginning of this year, Shanghai has started 32 new major projects with an investment of nearly 8 billion yuan, including the second phase of Bibo Bio's large-scale CDMO integrated platform, the construction project of Berger Medical Industrial Base, the intuitive Fosun headquarters and industrialization base, and the R&D capability and production quality improvement and transformation project of Hehuang Pharmaceutical.
-
The 2022 edition of the "Chinese Consensus on Panvascular Disease of Type 2 Diabetes" was released, and it is recommended that these three indicators be evaluated every year
Time of Update: 2022-11-05
Recently, the 2022 edition of the "China Expert Consensus on Risk Assessment and Management of Panvascular Disease in Patients with Type 2 Diabetes" (hereinafter referred to as the consensus) was rele
-
The highest price reduction was 94%, and the six major medical consumables began to be centrally purchased
Time of Update: 2022-10-31
Since then, the Shanxi Provincial Medical Insurance Bureau has guided each city to form three municipal alliances to carry out centralized procurement of low-value medical consumables on a regular basis.
-
Safety and efficacy of Pediatric Investigation Yuping granules in the treatment of recurrent respiratory infections in children: a randomized controlled clinical trial
Time of Update: 2022-10-01
Like, watch, share, come to a one-click triple!Recurrent respiratory infections (RRTI) are a common disease in children in China, with an incidence of 8.
Like, watch, share, come to a one-click triple!Recurrent respiratory infections (RRTI) are a common disease in children in China, with an incidence of 8.
-
To save his brother's life, Harvard graduates tailored gene therapy for him
Time of Update: 2022-09-09
▎ WuXi AppTec content team editorOn August 9, 2022, Cure Rare Disease (CRD), a Boston-based nonprofit organization, announced that the FDA had approved its IND application for a CRISPR gene-edited therapy called CRD-TMH-001 for the treatment of Duchenne muscular dystrophy (DMD).
-
25 pharmaceutical and biological companies were surveyed by more than 20 institutions
Time of Update: 2022-09-07
Among them, the net profit attributable to the parent company of two companies in the first half of the year increased by more than 50% year-on-year, namely Adopt Shares and Xiangsheng Medical.
-
Another innovative medical device has been approved for marketing, and 16 have been approved during the year
Time of Update: 2022-05-23
According to the public information of the State Food and Drug Administration, the innovative medical device "Magnetic Resonance Imaging System" produced by Xingaoyi Medical Equipment Co.
According to the list, the "Magnetic Resonance Imaging System" is the 16th innovative medical device approved this year .
-
How much has the national procurement changed the pattern of the pharmaceutical market
Time of Update: 2022-01-27
5%; The proportion of unselected generic drug purchases decreased by 37%, the largest decrease was omeprazole, which decreased by 69%, and the smallest decrease was imatinib, which decreased by only 2.
-
The knockout stage of the pharmaceutical industry is accelerating, and innovation is the key to development
Time of Update: 2022-01-22
In order to seize new market development opportunities, companies need to continuously increase investment in innovative drug research and development or promote the development of generic drugs with core values .
-
Clinical Guidelines for Radiotherapy of Small Cell Lung Cancer in China (2020 Edition
Time of Update: 2022-01-08
Source: Chinese Journal of Radiation OncologySource: Chinese Journal of Radiation Oncology Source: Chinese Journal of Radiation OncologyreferencesReferences ReferencesChinese Medical Association Radiation Oncology Therapeutics Branch, Chinese Medical Doctor Association Radiation Oncology Therapeutics Branch, Chinese Anti-Cancer Association Radiotherapy Professional Committee, Chinese Clinical Oncology Society Radiotherapy Expert Committee.
-
The seventh batch of nationally selected varieties meet the conditions (list attached
Time of Update: 2021-12-04
In addition, "Minenet" has also sorted out a group of anti-tumor drugs that meet the requirements of the national centralized procurement to be reviewed .
According to data from Meinenet, the anti-tumor drug market is expected to reach 300 billion in 2025 .
-
Correlation between antibiotic exposure and colorectal cancer
Time of Update: 2021-11-15
This article is from the NEJM Journal Watch Association Between Antibiotic Exposure and Colorectal Cancer.
A recent large-scale study revealed the association between antibiotic exposure and colorectal cancer, especially with proximal colon cancer (NEJM JW Gastroenterol Oct 2019 and Gut 2019; 68:1971) .
-
JAMA Sub-Journal: Don't want to get diabetes
Time of Update: 2021-10-22
Only for medical professionals to read and refer to clinical information, 1s to reach more cutting-edge clinical information, follow the clinical pharmacy channel to obtain the source of this article
